168 related articles for article (PubMed ID: 31943410)
1. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.
Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N
Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410
[TBL] [Abstract][Full Text] [Related]
2. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates.
Anselmi M; Borbély A; Figueras E; Michalek C; Kemker I; Gentilucci L; Sewald N
Chemistry; 2021 Jan; 27(3):1015-1022. PubMed ID: 32955139
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
4. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
[TBL] [Abstract][Full Text] [Related]
6. Conjugates of Cryptophycin and RGD or
Borbély A; Figueras E; Martins A; Bodero L; Raposo Moreira Dias A; López Rivas P; Pina A; Arosio D; Gallinari P; Frese M; Steinkühler C; Gennari C; Piarulli U; Sewald N
ChemistryOpen; 2019 Jun; 8(6):737-742. PubMed ID: 31275795
[TBL] [Abstract][Full Text] [Related]
7. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768
[TBL] [Abstract][Full Text] [Related]
9. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake.
Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D
Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540
[TBL] [Abstract][Full Text] [Related]
10. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
[TBL] [Abstract][Full Text] [Related]
11. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
Bianchi A; Arosio D; Perego P; De Cesare M; Carenini N; Zaffaroni N; De Matteo M; Manzoni L
Org Biomol Chem; 2015 Jul; 13(27):7530-41. PubMed ID: 26074454
[TBL] [Abstract][Full Text] [Related]
13. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
Paulus J; Nachtigall B; Meyer P; Sewald N
Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662
[TBL] [Abstract][Full Text] [Related]
14. Tumor Targeting with an isoDGR-Drug Conjugate.
Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
[TBL] [Abstract][Full Text] [Related]
15. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
[TBL] [Abstract][Full Text] [Related]
17. Multimerization Increases Tumor Enrichment of Peptide⁻Photosensitizer Conjugates.
Zhao J; Li S; Jin Y; Wang JY; Li W; Wu W; Hong Z
Molecules; 2019 Feb; 24(4):. PubMed ID: 30823562
[TBL] [Abstract][Full Text] [Related]
18. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]